Today: 21 May 2026
Browse Category

NASDAQ:IONQ 29 December 2025 - 8 January 2026

Quantum Computing Stocks Slide in Premarket After D-Wave’s $550 Million Quantum Circuits Deal

Quantum Computing Stocks Slide in Premarket After D-Wave’s $550 Million Quantum Circuits Deal

D-Wave Quantum shares fell 3.5% premarket to $30.20 after announcing a $550 million cash-and-stock deal to acquire Quantum Circuits. IonQ, Rigetti, Quantum Computing Inc, and Arqit also traded lower. SEC filings detail a stock-price collar between $22.30 and $39.03 for the equity portion. The deal can be terminated if not closed by April 6.
8 January 2026
····
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum shares jumped nearly 10% to around $30.91 Monday amid a surge in large call-option trades flagged by Benzinga. The rally comes ahead of D-Wave’s CES Foundry appearance Jan. 7–8, where investors are watching for new customer or partnership announcements. QBTS traded between $27.79 and $31.20, with about 31 million shares changing hands by mid-afternoon. Other U.S.-listed quantum stocks also rose.
5 January 2026
·····
Rigetti Computing stock steadies premarket after Needham fireside chat reveal — what RGTI investors watch next

Rigetti Computing stock steadies premarket after Needham fireside chat reveal — what RGTI investors watch next

Rigetti shares traded near $23.60 in premarket Monday after the company announced its CEO will speak at the Needham Growth Conference on Jan. 13. Investors await updates on hardware timelines and demand signals ahead of Rigetti’s next earnings report, expected March 5. The stock has swung between $5.96 and $58.15 in the past year.
5 January 2026
···
D-Wave Quantum stock jumps 8% before the bell as CES 2026 puts quantum back on traders’ radar

D-Wave Quantum stock jumps 8% before the bell as CES 2026 puts quantum back on traders’ radar

D-Wave Quantum shares jumped 7.6% to $28.13 in premarket trading Monday as CES 2026 opened in Las Vegas. Peer quantum stocks IonQ, Rigetti, and Quantum Computing Inc also traded higher. D-Wave is set to showcase its quantum systems at the CES Foundry event Jan. 7-8. The company’s Qubits 2026 user conference is scheduled for Jan. 27-28 in Boca Raton, Florida.
5 January 2026
·····
QBTS stock jumps as D-Wave Quantum rally puts CES 2026 and U.S. data in focus

QBTS stock jumps as D-Wave Quantum rally puts CES 2026 and U.S. data in focus

D-Wave Quantum shares jumped 7.6% to $28.13 Friday, with volume near 48 million. The stock traded between $25.44 and $28.42 as quantum-computing peers also advanced. Traders cited anticipation ahead of CES and key U.S. economic data next week. D-Wave remains unprofitable, with 2024 revenue of $8.83 million and a net loss of $143.88 million.
4 January 2026
·····
Why D-Wave Quantum (QBTS) stock jumped 8% — and what investors are watching next

Why D-Wave Quantum (QBTS) stock jumped 8% — and what investors are watching next

D-Wave Quantum Inc (QBTS) shares closed up 7.6% at $28.13 on Friday, with 48.4 million shares traded. The company will sponsor the CES Foundry event in Las Vegas on Jan. 7–8 and hold its Qubits 2026 user conference later in January. IonQ, Rigetti Computing, and Quantum Computing Inc also posted gains. Investors are watching for signs of commercial progress as D-Wave highlights new hardware and software.
3 January 2026
····
Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next

Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next

Pure-play quantum computing stocks jumped 4%–8% Friday, far outpacing the Russell 2000’s 1.1% gain. D-Wave Quantum closed up 7.6%, Quantum Computing Inc 7.3%, Rigetti 6.6%, and IonQ 4.3%. The rally came as investors rotated into higher-risk names at the start of 2026. Focus shifts to CES 2026 demos and next week’s U.S. jobs report.
3 January 2026
·····
D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

D-Wave Quantum shares rose about 3% to $26.95 by midday Friday, trading between $25.44 and $27.64 on heavy volume. The move followed gains in other quantum-computing stocks as tech led early 2026 market strength. Investors are watching D-Wave’s CES Foundry appearance Jan. 7-8 and the U.S. jobs report next week for further direction.
2 January 2026
·····
IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar

IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar

IBM aims to demonstrate “quantum advantage” in 2026, a milestone closely watched by investors. Shares of IBM and IonQ fell about 1.4% and 1.5% Friday morning, while Nvidia rose 1.9%. Zacks and Motley Fool both highlighted IBM, IonQ, and Nvidia as key quantum computing stocks for 2026. Most companies in the sector remain unprofitable as funding and interest build.
2 January 2026
···
Rigetti (RGTI) stock ends 2025 lower as year-end selling hits quantum names — what to watch next

Rigetti (RGTI) stock ends 2025 lower as year-end selling hits quantum names — what to watch next

Rigetti Computing shares closed down 1.2% at $22.15 Wednesday, then rose to $22.26 in late trading. Other U.S.-listed quantum computing stocks also slipped as Wall Street ended 2025 lower on thin volume. The S&P 500 finished the year up 16.39%, Nasdaq up 20.36%. U.S. markets will be closed Thursday for New Year’s Day.
1 January 2026
····
D-Wave Quantum (QBTS) stock today: what’s moving shares in early premarket trade

D-Wave Quantum (QBTS) stock today: what’s moving shares in early premarket trade

D-Wave Quantum shares held near $26.25 in quiet premarket trading Wednesday, capping a year with a 213% gain despite recent volatility. The company plans two January events, including a CES appearance, as traders eye updates on bookings and commercial traction. About 12% of D-Wave’s float is sold short. Next earnings are expected in March.
31 December 2025
···
Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti Computing shares rose 0.3% to $22.34 Tuesday afternoon after swinging 3% intraday. IonQ gained 1.2% and D-Wave Quantum advanced 1.6%, while the broader market was flat. Trading was thin ahead of year-end, with investors rotating within technology. The Federal Reserve’s December minutes showed policymakers split on further rate cuts.
30 December 2025
·····
Rigetti stock slips as quantum shares cool ahead of Fed minutes

Rigetti stock slips as quantum shares cool ahead of Fed minutes

Rigetti Computing shares fell 0.49% to $22.27 Monday and edged down to $22.24 after hours, extending a 17% pullback since Dec. 22. Volume reached 33.4 million shares. The company ended Q3 with over $600 million in liquidity, according to Zacks. Traders are watching if RGTI holds above $21.53 ahead of Federal Reserve minutes due Wednesday.
30 December 2025
······
IonQ stock today: IONQ slips after hours as South Korea 100‑qubit deal hits tape

IonQ stock today: IONQ slips after hours as South Korea 100‑qubit deal hits tape

IonQ shares fell 1.6% to $45.25 in after-hours trading after the company announced a deal to deliver a 100-qubit quantum system to South Korea’s KISTI for integration with its main supercomputing cluster. The company did not disclose financial terms. Traders are watching contract timing and the next earnings update for signs of commercialization progress.
30 December 2025
··
IonQ stock falls despite South Korea quantum-system deal as sector cools

IonQ stock falls despite South Korea quantum-system deal as sector cools

IonQ shares fell 2.5% to $44.85 after the company announced a deal to deliver a 100-qubit quantum system to South Korea’s KISTI. The Tempo 100 will be integrated into the country’s largest HPC cluster, marking South Korea’s first on-site hybrid quantum-classical setup. IonQ did not disclose financial terms or a delivery timeline. Trading volume reached 11.1 million shares by mid-afternoon.
29 December 2025
··
1 2 3 4 5 6

Stock Market Today

  • Australia Shares Set to Rise at Open, New Zealand Markets Dip
    May 20, 2026, 7:49 PM EDT. Australian shares are expected to open higher, signaling investor confidence in the region's market outlook. In contrast, New Zealand equities are projected to decline at the open, reflecting differing economic or market responses. Market data sourced from ICE Data Services with reference information provided by FactSet, supported by multiple financial data providers. The divergence underscores the varied regional market trends in Oceania at the start of the trading session.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop